CALLISTO PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | |
|---|---|---|
| Revenue | — | — |
| Operating income | −$125.3M | −$16.9M |
| Net income | −$123.3M | −$25.8M |
| Total assets | $14.5M | $3.4M |
| Total liabilities | $8.0M | $10.6M |
| Equity | $26.2M | $3.9M |
| EPS (diluted) | — | — |
| Shares out. | 158.5M | 157.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- —
- Net margin
- —
- Return on equity
- −470.8%
- Return on assets
- −849.4%
- Return on capital (ROCE)
- −1272.1%
- Liabilities / assets
- 55.1%
- Debt / equity
- 0.31×
- Book value / share
- $0.17
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Altman Z″ (distress)
- -82.14distress
- Accruals / assets
- −218.9%clean
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2012
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2012
- NT 10-Qmissed a reporting deadline ↗May 15, 2009
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2009
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2008
- NT 10-Qmissed a reporting deadline ↗May 15, 2007
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Shareholder voteJan 15, 2013
- Other material eventJan 3, 2013
- Entered a material agreementOct 16, 2012
- Entered a material agreement · Other material eventJul 23, 2012
- Director / officer changeApr 19, 2011
- Entered a material agreement · Unregistered equity saleDec 16, 2010
- Director / officer changeMay 27, 2010
- Entered a material agreement · Unregistered equity saleMar 23, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.